Opportunity Information: Apply for BAA OAA RM 2017 ADDENDUM01
The "BROAD AGENCY ANNOUNCEMENT: IMPROVING URBAN HEALTH IN ASIA" (Funding Opportunity Number: BAA OAA RM 2017 ADDENDUM01) is a USAID discretionary funding opportunity focused on improving health outcomes in Asia's rapidly growing urban areas. The opportunity is grounded in the idea that as cities expand and change quickly, traditional development approaches are often too slow or too narrowly focused to keep up. Instead, USAID is signaling interest in practical, locally driven, and cross-sector solutions that reflect what urban residents themselves consider meaningful health outcomes, including populations that are often overlooked in citywide averages.
A central theme of the announcement is that lasting progress in urban health depends on genuine local leadership and investment. USAID emphasizes that accurate understanding of priority outcomes cannot be achieved without engagement from local government institutions, civil society organizations, and the private sector. Just as importantly, the announcement stresses that progress will not be sustained over time unless those local actors are fully bought in and willing to commit their own capacity, influence, and resources. In other words, this is not framed as an external program delivered to cities, but as a partnership model where local institutions play a leading role and where solutions are shaped by the realities of specific urban contexts.
The opportunity also highlights that urban health problems are not solvable by the health sector alone. The announcement points to the need for collaboration well beyond health agencies or clinics, reflecting how city health outcomes are closely tied to housing, water and sanitation, transportation, environmental quality, employment conditions, education, and broader urban governance. This cross-sector orientation implies that competitive concepts would likely connect health improvements to the systems that shape everyday urban life, rather than focusing only on direct medical services. The underlying message is that lasting well-being in cities requires aligning multiple sectors and incentives so that healthier outcomes are built into how cities function.
Another major emphasis is Asia's pace of development and the presence of diverse "change agents" across the region. USAID explicitly notes that Asia's dynamism requires a shift beyond traditional development programming and expresses interest in partnering with a wide range of actors, from established institutions to disruptive innovators. This framing opens the door to approaches that may include new technologies, novel financing or business models, data-driven decision-making, and unconventional partnerships, as long as they can credibly accelerate progress on urban health challenges. The goal is to catalyze new ways of solving problems, not simply replicate standard interventions.
From an administrative standpoint, the listing identifies the agency as the Agency for International Development (USAID) and categorizes the activity under Health, with CFDA number 98.001. The eligibility is listed as "Unrestricted," indicating that a broad array of applicants may be able to participate, depending on the specific terms and any additional requirements in the full announcement or addendum. The funding instrument type is labeled "Other," which often suggests flexible partnership or procurement mechanisms rather than a standard grant format, consistent with the announcement's emphasis on collaboration and innovation. The posting shows a creation date of February 8, 2017, with an original closing date of March 24, 2017. The award ceiling is shown as 0 and expected awards are not specified in the provided data, which commonly indicates that award size and number may vary by concept, may be determined later, or may depend on available funding and the merit of proposals received.
Overall, this opportunity is best understood as a call for partnerships that can produce measurable, locally relevant improvements in urban health in Asian cities by aligning local leadership, cross-sector collaboration, and innovative problem-solving. The intent is not only to achieve better outcomes in the near term, but also to build solutions that are owned locally and durable enough to continue after external support declines.Apply for BAA OAA RM 2017 ADDENDUM01
- The Agency for International Development in the health sector is offering a public funding opportunity titled "BROAD AGENCY ANNOUNCEMENT: IMPROVING URBAN HEALTH IN ASIA" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2017-02-08.
- Applicants must submit their applications by 2017-03-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: BROAD AGENCY ANNOUNCEMENT: Improving Urban Health in Asia (BAA OAA RM 2017 ADDENDUM01)
What is the name of this funding opportunity?
The opportunity is titled "BROAD AGENCY ANNOUNCEMENT: IMPROVING URBAN HEALTH IN ASIA."
What is the Funding Opportunity Number?
The Funding Opportunity Number is BAA OAA RM 2017 ADDENDUM01.
Which agency is offering this opportunity?
The issuing agency is the Agency for International Development (USAID).
What is the main purpose of this announcement?
The purpose is to improve health outcomes in Asia's rapidly growing urban areas by supporting practical, locally driven, cross-sector solutions that reflect what urban residents consider meaningful health outcomes, including populations often missed by citywide averages.
What region and setting does the opportunity focus on?
The focus is on Asia, specifically in rapidly growing urban areas (cities and urban contexts).
Why is USAID emphasizing urban health in Asia?
The announcement is grounded in the idea that cities in Asia are expanding and changing quickly, and that traditional development approaches can be too slow or too narrowly focused to keep up with the pace and complexity of urban change.
What kinds of approaches is USAID signaling interest in?
USAID signals interest in practical, locally driven, cross-sector approaches shaped by the realities of specific cities. The framing also points to innovative problem-solving, including potential use of new technologies, novel financing or business models, data-driven decision-making, and unconventional partnerships when they can credibly accelerate progress on urban health challenges.
Does the announcement expect solutions to come only from the health sector?
No. A central theme is that urban health problems are not solvable by the health sector alone. The opportunity highlights the need for collaboration beyond health agencies and clinics, reflecting the way health outcomes are tied to broader urban systems.
What non-health sectors are mentioned as relevant to urban health outcomes?
The announcement connects urban health outcomes to housing, water and sanitation, transportation, environmental quality, employment conditions, education, and broader urban governance.
How important is local leadership to this opportunity?
Local leadership is presented as essential. USAID emphasizes that priority outcomes cannot be accurately understood without engagement from local government institutions, civil society organizations, and the private sector.
What does USAID mean by local ownership and investment?
The announcement stresses that progress will not be sustained unless local actors are fully bought in and willing to commit their own capacity, influence, and resources. The opportunity is framed more as a partnership model than an external program delivered to cities.
Who does USAID want involved as partners or stakeholders?
Based on the announcement, USAID highlights engagement from local government institutions, civil society organizations, and the private sector, along with a wider range of actors including established institutions and disruptive innovators.
What does "cross-sector" mean in the context of this opportunity?
In this announcement, cross-sector means connecting health improvements to the systems that shape everyday urban life (for example housing, sanitation, transportation, environmental conditions, employment, education, and governance), rather than focusing only on direct medical services.
Is this opportunity open to innovative or non-traditional actors?
Yes. The announcement explicitly notes Asia's dynamism and expresses interest in partnering with a wide range of actors, from established institutions to disruptive innovators, to catalyze new ways of solving urban health problems.
What is the program area or category for this listing?
The activity is categorized under Health.
What is the CFDA number?
The CFDA number listed is 98.001.
What is the eligibility status?
Eligibility is listed as "Unrestricted," which indicates that a broad array of applicants may be able to participate, subject to the specific terms and any additional requirements in the full announcement or addendum.
What is the funding instrument type?
The funding instrument type is labeled "Other," which often suggests flexible partnership or procurement mechanisms rather than a standard grant format, aligning with the announcement's emphasis on collaboration and innovation.
When was this opportunity created (posted)?
The listing shows a creation date of February 8, 2017.
What was the original closing date?
The original closing date shown is March 24, 2017.
What is the award ceiling?
The award ceiling is shown as 0 in the provided listing data, which commonly indicates that award size may vary by concept, may be determined later, or may depend on available funding and the merit of proposals received.
How many awards are expected?
Expected awards are not specified in the provided data.
Does the announcement describe what success should look like?
It emphasizes measurable, locally relevant improvements in urban health outcomes, shaped by what urban residents consider meaningful, and designed to be durable through local ownership after external support declines.
How does the opportunity address equity or overlooked populations?
The announcement explicitly highlights interest in outcomes that include populations often overlooked in citywide averages, implying attention to groups whose health needs may not be visible when only aggregate city indicators are used.
Is this opportunity more about short-term projects or long-term durability?
The intent includes near-term improvements, but it strongly emphasizes durability and sustainability through genuine local buy-in, leadership, and investment so that solutions can continue after external support declines.
What is the overall takeaway for applicants or partners?
This is best understood as a call for partnerships that can accelerate meaningful improvements in urban health in Asian cities by combining local leadership, cross-sector collaboration, and innovative problem-solving tailored to specific urban contexts.
Browse more opportunities from the same category: Health
Next opportunity: 2017 Survey and Clearance in Kabul/Laghman (Project 15)
Previous opportunity: Vietnam localworks for Environmental Health
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for BAA OAA RM 2017 ADDENDUM01
Applicants also applied for:
Applicants who have applied for this opportunity (BAA OAA RM 2017 ADDENDUM01) also looked into and applied for these:
| Funding Opportunity |
|---|
| Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33) Apply for PAR 17 162 Funding Number: PAR 17 162 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33) Apply for PAR 17 149 Funding Number: PAR 17 149 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Oral HIV Vaccination: Strategy Synergistic to Systemic Vaccination (R01) Apply for RFA DE 18 008 Funding Number: RFA DE 18 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NCATS Pilot Program for Collaborative Drug Discovery Research using Bioprinted Skin Tissue (U18) Apply for RFA TR 17 007 Funding Number: RFA TR 17 007 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34) Apply for PA 17 166 Funding Number: PA 17 166 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Research to Support the Reduction and Elimination of Mental Health Disparities (Admin Supp) Apply for PA 17 165 Funding Number: PA 17 165 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Rwandan Health Service Delivery Activity (RSDA) Apply for RFI 696 17 000001 Funding Number: RFI 696 17 000001 Agency: Rwanda USAID-Kigali Category: Health Funding Amount: Case Dependent |
| Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02) Apply for RFA TR 17 001 Funding Number: RFA TR 17 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (UG3/UH3) Apply for RFA TR 17 002 Funding Number: RFA TR 17 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses for Existing Molecules (UG3/UH3) Apply for RFA TR 17 003 Funding Number: RFA TR 17 003 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50) Apply for PAR 17 168 Funding Number: PAR 17 168 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01) Apply for RFA MH 18 200 Funding Number: RFA MH 18 200 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| HIV pathogenesis and the oral microbiota (R01) Apply for RFA DE 18 007 Funding Number: RFA DE 18 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Research Resource Awards (R24) Apply for PAR 17 170 Funding Number: PAR 17 170 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regional Consortia for High Resolution Cryoelectron Microscopy (U24) Apply for RFA GM 17 005 Funding Number: RFA GM 17 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (U01) Apply for PAR 17 179 Funding Number: PAR 17 179 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Neoantigen-Based Therapeutic Targeting of Head and Neck Cancers (R01) Apply for RFA DE 18 004 Funding Number: RFA DE 18 004 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Neuroskeletal Biology of the Dental and Craniofacial Skeletal System (R01) Apply for RFA DE 18 005 Funding Number: RFA DE 18 005 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Neuroskeletal Biology of the Dental and Craniofacial Skeletal System (R21) Apply for RFA DE 18 006 Funding Number: RFA DE 18 006 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative U01) Apply for PAR 17 176 Funding Number: PAR 17 176 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "BAA OAA RM 2017 ADDENDUM01", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.